Evidence map›Paper›PMID 24335742›Full record

ArticleSexually transmitted diseases2014

Replacing clinic-based tests with home-use tests may increase HIV prevalence among Seattle men who have sex with men: evidence from a mathematical model.

David A Katz, Susan L Cassels, Joanne D Stekler

Abstract read
In one paragraph

Article in Sexually transmitted diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Evidence for optimal HIV screening and testing intervals in HIV-negative individuals from various risk groups: A systematic review.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2018
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

David A KatzFrom the Departments of *Medicine, †Epidemiology, and ‡Global Health, University of Washington, Seattle, WA; and §HIV/STD Program, Public Health-Seattle & King County, Seattle, WA.
Susan L Cassels
Joanne D Stekler

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
Methods and Data CoreR24HD042828 · NICHD · UNIVERSITY OF WASHINGTON · PI ELLIS, JOHN MARK · 2002 to 2016
$9.3M
Comparisons of Public Health Screening Methods for Acute and Early HIV InfectionR01MH086360 · NIMH · UNIVERSITY OF WASHINGTON · PI STEKLER, JOANNE DONNA · 2009 to 2013
$2.5M
Migration to Urban Slums, Sexual Networks, and HIV in GhanaR00HD057553 · NICHD · UNIVERSITY OF WASHINGTON · PI CASSELS, SUSAN LYNN · 2010 to 2012
$700k
NIAID NIH HHS P30 AI027757NICHD NIH HHS R00HD057533NICHD NIH HHS R00 HD057553NICHD NIH HHS R24 HD042828NIMH NIH HHS R01 MH086360NIMH NIH HHS R01MH086360
6 · The paper itself

Abstract

backgroundHome-use tests have potential to increase HIV testing but may increase the rate of false-negative tests and decrease linkage to HIV care. We sought to estimate the impact of replacing clinic-based testing with home-use tests on HIV prevalence among men who have sex with men (MSM) in Seattle, Washington.

methodsWe adapted a deterministic, continuous-time model of HIV transmission dynamics parameterized using a 2003 random digit dial study of Seattle MSM. Test performance was based on the OraQuick In-Home HIV Test (OraSure Technologies, Inc, Bethlehem, PA) for home-use tests and, on an average, of antigen-antibody combination assays and nucleic acid amplification tests for clinic-based testing.

resultsBased on observed levels of clinic-based testing, our baseline model predicted an equilibrium HIV prevalence of 18.6%. If all men replaced clinic-based testing with home-use tests, prevalence increased to 27.5% if home-use testing did not impact testing frequency and to 22.4% if home-use testing increased testing frequency 3-fold. Regardless of how much home-use testing increased testing frequency, any replacement of clinic-based testing with home-use testing increased prevalence. These increases in HIV prevalence were mostly caused by the relatively long window period of the currently approved test. If the window period of a home-use test were 2 months instead of 3 months, prevalence would decrease if all MSM replaced clinic-based testing with home-use tests and tested more than 2.6 times more frequently.

conclusionsOur model suggests that if home-use HIV tests replace supplement clinic-based testing, HIV prevalence may increase among Seattle MSM, even if home-use tests result in increased testing.

Indexed as

Homosexuality, MaleNucleic Acid Amplification TechniquesReagent Kits, DiagnosticSelf CareSexual BehaviorAdultAmbulatory Care FacilitiesCondomsFalse Negative ReactionsHealth Knowledge, Attitudes, PracticeHealth Services AccessibilityHIV SeropositivityHumansMaleMass ScreeningModels, TheoreticalReagent Kits, Diagnostic

Identifiers

PMID24335742
PMCPMC3955208

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.